{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T08:40:21Z","timestamp":1767516021049,"version":"3.48.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":299,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IDCases"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.idcr.2025.e02410","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:11:09Z","timestamp":1761696669000},"page":"e02410","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Tailored management of chronic bacterial prostatitis with sequential fluoroquinolones and adverse effect mitigation strategies: A case report"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-0490-6317","authenticated-orcid":false,"given":"Thao D.","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.idcr.2025.e02410_bib1","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1046\/j.1439-0272.2003.00557.x","article-title":"Classification and diagnosis of prostatitis: a gold standard?","volume":"35","author":"Nickel","year":"2003","journal-title":"Andrologia"},{"issue":"1","key":"10.1016\/j.idcr.2025.e02410_bib2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijantimicag.2007.08.025","article-title":"Concentrations of moxifloxacin in plasma and urine, and penetration into prostatic fluid and ejaculate, following single oral administration of 400 mg to healthy volunteers","volume":"31","author":"Wagenlehner","year":"2008","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"10.1016\/j.idcr.2025.e02410_bib3","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1128\/AAC.48.3.1012-1016.2004","article-title":"In vitro activities of moxifloxacin against 900 aerobic and anaerobic surgical isolates from patients with intra-abdominal and diabetic foot infections","volume":"48","author":"Edmiston","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.idcr.2025.e02410_bib4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1365-2605.1998.00110.x","article-title":"The possible role of anaerobic bacteria in chronic prostatitis","volume":"21","author":"Sz\u00f6ke","year":"1998","journal-title":"Int J Androl"},{"issue":"3","key":"10.1016\/j.idcr.2025.e02410_bib5","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.anaerobe.2009.10.008","article-title":"A severely symptomatic case of anaerobic chronic bacterial prostatitis successfully resolved with moxifloxacin therapy","volume":"16","author":"Magri","year":"2010","journal-title":"Anaerobe"},{"issue":"2","key":"10.1016\/j.idcr.2025.e02410_bib6","doi-asserted-by":"crossref","first-page":"S144","DOI":"10.1086\/428055","article-title":"Antimicrobial safety: focus on fluoroquinolones","volume":"41","author":"Owens","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"18","key":"10.1016\/j.idcr.2025.e02410_bib7","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.3748\/wjg.v16.i18.2202","article-title":"Systematic review and meta-analysis of Saccharomyces boulardii in adult patients","volume":"16","author":"McFarland","year":"2010","journal-title":"World J Gastroenterol"},{"issue":"12","key":"10.1016\/j.idcr.2025.e02410_bib8","article-title":"Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children","volume":"12","author":"Goldenberg","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.idcr.2025.e02410_bib9","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/apt.13404","article-title":"Systematic review with meta-analysis: Lactobacillus rhamnosus GG in the prevention of antibiotic-associated diarrhoea in children and adults","volume":"42","author":"Szajewska","year":"2015","journal-title":"Aliment Pharm Ther"},{"key":"10.1016\/j.idcr.2025.e02410_bib10","unstructured":"Product information, Culturelle\u00ae. Digestive Daily Probiotic [Internet]. Culturelle; [cited 2025 Oct 18]. Available from: \u3008https:\/\/culturelleprobiotic.ca\/products\/digestive-daily-probiotic\u3009."},{"issue":"6","key":"10.1016\/j.idcr.2025.e02410_bib11","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.chom.2018.05.012","article-title":"The impact of dietary fiber on gut microbiota in host health and disease","volume":"23","author":"Makki","year":"2018","journal-title":"Cell Host Microbe"},{"issue":"9","key":"10.1016\/j.idcr.2025.e02410_bib12","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s40264-013-0089-8","article-title":"Tendon injury and fluoroquinolone use: a systematic review","volume":"36","author":"Stephenson","year":"2013","journal-title":"Drug Saf"},{"issue":"2","key":"10.1016\/j.idcr.2025.e02410_bib13","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3390\/biology11020172","article-title":"Exercise effects on the biomechanical properties of the achilles tendon-a narrative review","volume":"11","author":"Yu","year":"2022","journal-title":"Biology"},{"issue":"1","key":"10.1016\/j.idcr.2025.e02410_bib14","article-title":"The effects of Type I Collagen hydrolysate supplementation on bones, muscles, and joints: a systematic review","volume":"17","author":"Brueckheimer","year":"2025","journal-title":"Orthop Rev"},{"issue":"5","key":"10.1016\/j.idcr.2025.e02410_bib15","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/2042098612454283","article-title":"Drug-induced QT interval prolongation: mechanisms and clinical management","volume":"3","author":"Nachimuthu","year":"2012","journal-title":"Ther Adv Drug Saf"},{"issue":"1","key":"10.1016\/j.idcr.2025.e02410_bib16","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1542-474X.2006.00082.x","article-title":"Effects of three fluoroquinolones on QT analysis after standard treatment courses","volume":"11","author":"Tsikouris","year":"2006","journal-title":"Ann Noninvasive Electro"},{"issue":"1","key":"10.1016\/j.idcr.2025.e02410_bib17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijcard.2013.03.063","article-title":"Swimming and the heart","volume":"168","author":"Lazar","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.idcr.2025.e02410_bib18","doi-asserted-by":"crossref","first-page":"504","DOI":"10.3389\/fphar.2020.00504","article-title":"Pharmacological Interventions for Bacterial Prostatitis","volume":"11","author":"Xiong","year":"2020","journal-title":"Front Pharm"},{"key":"10.1016\/j.idcr.2025.e02410_bib19","unstructured":"Pendegast H.J., Leslie S.W., Rosario D.J. Chronic prostatitis and chronic pelvic pain syndrome in men. [Updated 2024 Jan 11]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: \u3008https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK599550\/\u3009."},{"key":"10.1016\/j.idcr.2025.e02410_bib20","doi-asserted-by":"crossref","unstructured":"Lai H.H., Pontari M.A., Argoff C.E., Bresler L., Breyer B.N., Chou R., et al. Male chronic pelvic pain: AUA guideline. Part I: Evaluation and management approach (pp. 1\u201311; PMID: 40243110) and Part II: Treatment of chronic prostatitis\/chronic pelvic pain syndrome (pp. 127\u2013137; PMID: 40243102). J Urol. 2025; 214(2).","DOI":"10.1097\/JU.0000000000004565"}],"container-title":["IDCases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250925002665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250925002665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T08:36:12Z","timestamp":1767515772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214250925002665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":20,"alternative-id":["S2214250925002665"],"URL":"https:\/\/doi.org\/10.1016\/j.idcr.2025.e02410","relation":{},"ISSN":["2214-2509"],"issn-type":[{"type":"print","value":"2214-2509"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tailored management of chronic bacterial prostatitis with sequential fluoroquinolones and adverse effect mitigation strategies: A case report","name":"articletitle","label":"Article Title"},{"value":"IDCases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idcr.2025.e02410","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e02410"}}